Physician profile
Brian Geraci
NPI 1487661096
$1,439.52
in general payments reported to CMS, 2019-2025
18 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.30 · 2020: $29.77 · 2021: $40.16 · 2022: $13.73 · 2023: $310 · 2024: $493 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $362.82 | 2023-2025 | Repatha, Evenity, Repatha |
| Novo Nordisk INC | $239.14 | 2019-2025 | Ozempic, Rybelsus, Rivfloza |
| Pfizer INC. | $133.08 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $122.22 | 2024-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $106.64 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Abbvie INC. | $102.92 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $93.23 | 2022-2025 | |
| Daiichi Sankyo INC. | $46.25 | 2021-2024 | Injectafer |
| Phathom Pharmaceuticals, INC. | $45.21 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $42.41 | 2019-2020 | |
| Exact Sciences Corporation | $28.16 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $24.78 | 2023 | |
| Phadia US INC. | $21.19 | 2025 | Immunocap |
| Corcept Therapeutics | $17.51 | 2025 | Korlym |
| Abbott Laboratories | $17.47 | 2025 | Freestyle Libre 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.28 | 2019 | |
| Medtronic Vascular, INC. | $11.21 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Geraci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.